Assessment of bleeding in patients with disseminated intravascular coagulation after surgical treatment receiving recombinant human soluble thrombomodulin: A cohort study using DPC database - Assessment of bleeding in patients with disseminated intravascular coagulation after surgical treatment receiving recombinant human soluble thrombomodulin: A cohort study using DPC database

CAC Croit Corporation0 个研究点目标入组 10,000 人开始时间: 2018年1月24日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients who do not have even 1 record of outcome information or who do not have outcome information in the hospital admission and discharge data at the time of initial diagnosis of DIC 2. Patients aged under 18 years 3. Patients with DIC in the department of gynecology/obstetrics (pregnant or possibly pregnant women to be contraindicated) 4. Patients who died within 2 days after the day of admission 5. Patients who received surgery on a day that is not in the same month as or in the month before the diagnosis of DIC 6. Patients who had not received DIC treatment 7. Patients who had received the initial dose of DIC treatment prior to the day of surgery or more than 1 week after surgery 8. Patients whose blood test data ("peripheral blood general") are not available 9. Patients who had intracranial hemorrhage, pulmonary hemorrhage, or gastrointestinal hemorrhage before DIC treatment (patients to be contraindicated) 10. Patients who had at least 1 dose of rTM, but no initial prescription of rTM on the day of surgery or within 1 week after that

发起方

CAC Croit Corporation